Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis

Ítems similars

• Anti-Carbamylated Protein Antibody Levels Correlate With Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis
  per: Challener, Gregory J., et al.
  Publicat: (2015)
• Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis
  per: Carrier, Nathalie, et al.
  Publicat: (2016)
• Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
  per: Vossenaar, Erik R, et al.
  Publicat: (2004)
• Benefit of early treatment in inflammatory polyarthritis patients with anti–cyclic citrullinated peptide antibodies versus those without antibodies
  per: Farragher, Tracey M, et al.
  Publicat: (2010)
• Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis
  per: Burr, Marian L, et al.
  Publicat: (2012)